UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.     )*

Cambridge Capital Acquisition Corporation

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

13215Q106

(CUSIP Number)

December 18, 2015

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨   Rule 13d-1(b)

x  Rule 13d-1(c)

¨   Rule 13d-1(d)

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

525 South Flagler Drive, Suite 201

West Palm Beach, FL 33401

This statement is filed by J.P. Morgan Investment Management Inc. (“JPMIM”) and the National Council for Social Security Fund (“SSF,” together with JPMIM, the “Reporting Persons”).

For JPMIM:

320 Park Avenue

New York, New York 10022

For SSF:

South Tower, Fortune Time, Building 11

Fenghuiyuan, Xicheng District

Beijing, People’s Republic of China 100032

For JPMIM, Delaware. For SSF, China.

Common Stock, par value $0.0001 per share (“Common Stock”)

13215Q106

Not Applicable.

The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover page to this Schedule 13G.

The percent of class represented by the amount beneficially owned by each Reporting Person is based on 10,534,625 shares of Common Stock outstanding on November 24, 2015, as reported in the Issuer’s Proxy Statement on Schedule 14A, filed on December 2, 2015.

The shares of Common Stock to which JPMIM has shared voting or dispositive power consists of (i) 1,029,963 shares held by SSF and (ii) 13,037 ordinary shares held by 522 Fifth Avenue Fund, L.P. (“522 Fund”). JPMIM serves as investment advisor to 522 Fund and SSF.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ¨.

Not applicable.

Not applicable.

Not applicable.

Not applicable.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated December 18, 2015

Exhibit 99.1

JOINT FILING AGREEMENT

The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (the “Act”), and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. Nothing herein shall be deemed to be an admission that the parties hereto, or any of them, are members of a “group” (within the meaning of Section 13(d) of the Act and the rules promulgated thereunder) with respect to any securities of Cambridge Capital Acquisition Corporation.

Dated December 18, 2015